A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations

Clinical trial NCT02109016 · TERMINATED

Trial details

NCT number: NCT02109016
Sponsor: Clovis Oncology, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Squamous Non-Small Cell Lung Cancer NSCLC Small Cell Lung Cancer SCLC Lung Cancer Advanced Lung Cancer Metastatic Lung Cancer Stage IV Lung Cancer

Start date: 2014-04-01
Primary completion: 2016-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.